Osimertinib trials for Stage IV Lung Cancer AJCC v8

All Osimertinib trials · All Stage IV Lung Cancer AJCC v8 trials

Phase breakdown

Recruiting trials studying Osimertinib for Stage IV Lung Cancer AJCC v8

• Biologically Guided Radiation Therapy (BgRT) and Stereotactic Body Radiation Therapy (SBRT) to Tyrosine Kinase Inhibitor in Oligoprogressive Oncogenic Positive Non-Small Cell Lung Carcinoma
  NCT06014827 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
  NCT05642572 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 454 locations
• MRX-2843 and Osimertinib for the Treatment of Advanced EGFR Mutant Non-small Cell Lung Cancer
  NCT04762199 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
  NCT04181060 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 603 locations

Common questions

How many trials study Osimertinib for Stage IV Lung Cancer AJCC v8?

4 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.